On February 19, 2026 (Beijing Time), two landmark studies from Xinhua Hospital and Songjiang Research Institute in collaboration with other partners, were simultaneously published in Nature. The two studies achieved global breakthroughs in AI-powered diagnosis of rare diseases and gene therapy for neurodevelopmental disorders.Professor Sun Kun’s Team Unveils DeepRare: A Globally First Traceabl...

From February 9 to 12, 2026, the Dubai World Health Expo 2026 (WHX 2026) was held in Dubai, United Arab Emirates. Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, showcased its “Integrated Smart Hospital Solution” and six major smart healthcare innovations, presenting China’s latest achievements in AI-enabled healthcare to a global audience.With a history spa...

On January 28, 2026 (local time), a research team led by Xu Huaqiang, researcher at the Center for Translational Medicine and Structural Biology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, together with colleagues from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, published a research article entitled “Structures of Ostα–β reveal a unique fol...

 On January 30, a delegation led by Professor Joseph Sung, Senior Vice President of Nanyang Technological University (NTU) and Dean of its LKCMedicine, visited Shanghai Jiao Tong University School of Medicine. The delegation was received by Chancellor Professor Fan Xianqun and Vice Chancellor Professor Zheng Junke, as well as representatives from the Office of International Affairs, Dean’s Off...

Shanghai Jiao Tong University School of Medicine remains closely aligned with national strategic priorities, committed to advancing the frontiers of global science and technology,addressing major national needs, and safeguarding public health. Guided by problem-oriented and demand-driven principles, and propelled by major scientific missions, the university continues to strengthen organized res...

​On January 14, the SACHI study led by Professor Lu Shun, academic leader of oncology at Shanghai Jiao Tong University School of Medicine Affiliated Chest Hospital and Director of the Shanghai Clinical Research Center for Lung Cancer, achieved a major breakthrough. The study was published in The Lancet. The research introduces a new precision treatment strategy—a “dual-target” regimen—for ...